Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-11-25 | New | $48,214,232 | $48,214,232 | Equity Only | 06b | SEC link |
| 2024-12-26 | New | $50,388,557 | $50,388,557 | Equity Only | 06b | SEC link |
| 2022-01-21 | New | $63,510,835 | $63,510,835 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Peter Colabuono | Director |
| Alan Colowick | Director |
| David Johnson | Director, Executive |
| Clayton D. Knox | Executive |
| Daniel Mc Hugh | Director |
| Langdon Miller | Executive |
| Robert Mittendorff | Director |
| Jason Pitts | Director |